|
|
|
Volumn 2, Issue 1, 2000, Pages 35-39
|
|
First generation leishmaniasis vaccines in clinical development: Moving, but what next?
|
|
Author keywords
Clinical trial; Cutaneous; Leishmaniasis; Vaccine; Visceral
|
|
Indexed keywords
ANTIMONY DERIVATIVE;
BCG VACCINE;
LEISHMANIA VACCINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOTHERAPY;
LEISHMANIA;
LEISHMANIA DONOVANI;
LEISHMANIA MAJOR;
LEISHMANIA MEXICANA;
LEISHMANIA TROPICA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SKIN LEISHMANIASIS;
VACCINATION;
|
|
EID: 0034096110
PISSN: 14648458
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (29)
|
|
References (14)
|
